Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by G7 Countries: Proportion of Ear Infections to Ear Nose Throat Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Ear Infections to Ear Nose Throat Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Ear Infections Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profile Snapshots 34
Appendix 52
Abbreviations 52
Definitions 52
Research Methodology 53
Secondary Research 53
About GlobalData 54
Contact Us 54
Source 54

List of Tables
Ear Infections Therapeutics, Global, Clinical Trials by Region, 2017* 7
Ear Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Ear Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Ear Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Ear Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Ear Infections Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Ear Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
Proportion of Ear Infections to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2017* 16
Ear Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Ear Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Ear Infections to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2017* 20
Ear Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Ear Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
Ear Infections Therapeutics, Global, Clinical Trials by Phase, 2017* 23
Ear Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 24
Ear Infections Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
Ear Infections Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Ear Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Ear Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 28
Ear Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
Ear Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
Ear Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33

List of Figures
Ear Infections Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Ear Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Ear Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Ear Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Ear Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Ear Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Proportion of Ear Infections to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2017* 15
Ear Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Ear Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Ear Infections to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2017* 19
Ear Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Ear Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
Ear Infections Therapeutics, Global, Clinical Trials by Phase (%), 2017* 23
Ear Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 24
Ear Infections Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
Ear Infections Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Ear Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Ear Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 28
Ear Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
Ear Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
Ear Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33
GlobalData Methodology 53

Companies Mentioned
- Centrafarm BV
- GlaxoSmithKline Plc
- Laboratorios SALVAT SA
- Hill Dermaceuticals Inc
- Highmark Inc
- Dr. Reddy's Laboratories Ltd
- China National Pharmaceutical Group Corp
- Bfactory Health Products BV
- Arbro Pharmaceuticals Ltd
- AmpliPhi Biosciences Corp